BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 30763745)

  • 1. Pneumatosis Intestinalis After Molecular-Targeted Therapy.
    Chaudhry NS; Bi WL; Gupta S; Keraliya A; Shimizu N; Chiocca EA
    World Neurosurg; 2019 May; 125():312-315. PubMed ID: 30763745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumatosis intestinalis and bowel perforation associated with molecular targeted therapy: an emerging problem and the role of radiologists in its management.
    Shinagare AB; Howard SA; Krajewski KM; Zukotynski KA; Jagannathan JP; Ramaiya NH
    AJR Am J Roentgenol; 2012 Dec; 199(6):1259-65. PubMed ID: 23169717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumatosis cystoides intestinalis in a trauma patient presenting with pneumoperitoneum: a case report.
    Lebby E; Hanna M; Bui TL; Rudd A; Lee W; Houshyar R
    J Med Case Rep; 2021 Dec; 15(1):597. PubMed ID: 34915922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A Case of Colorectal Cancer with Asymptomatic Idiopathic Pneumatosis Intestinalis during Bevacizumab Administration].
    Asada Y; Baba H; Tokizawa K; Ikeda Y; Takagi C; Fujii T; Okamoto N; Takeshima K; Asami A; Yamafuji K; Kubochi K
    Gan To Kagaku Ryoho; 2020 Jul; 47(7):1109-1111. PubMed ID: 32668863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumatosis cystoides intestinalis presenting as pneumoperitoneum in a patient with chronic obstructive pulmonary disease: a case report.
    Iida A; Naito H; Tsukahara K; Yumoto T; Nosaka N; Kawana S; Sato K; Takeuchi N; Soneda J; Nakao A
    J Med Case Rep; 2017 Feb; 11(1):55. PubMed ID: 28241852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign pneumatosis intestinalis in the setting of celiac disease.
    Nathan H; Singhal S; Cameron JL
    J Gastrointest Surg; 2006 Jun; 10(6):890-4. PubMed ID: 16769547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successfully treated pneumatosis cystoides intestinalis with pneumoperitoneum onset in a patient administered α-glucosidase inhibitor.
    Tanabe S; Shirakawa Y; Takehara Y; Maeda N; Katsube R; Ohara T; Sakurama K; Noma K; Fujiwara T
    Acta Med Okayama; 2013; 67(2):123-8. PubMed ID: 23603930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumatosis cystoides intestinalis as a rare cause of non-surgical pneumoperitoneum.
    Kotek J; Dušek T; Sirový M; Odložilová Š; Kašparová P; Čečka F
    Rozhl Chir; 2023; 102(5):214-218. PubMed ID: 37527949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumatosis cystoides intestinalis: an unusual cause of intestinal ischemia and pneumoperitoneum.
    Ogul H; Pirimoglu B; Kisaoglu A; Karaca L; Havan N; Ozogul B; Kantarci M
    Int Surg; 2015 Feb; 100(2):221-4. PubMed ID: 25692421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Massive pneumatosis intestinalis: CT diagnosis.
    Ryback LD; Shapiro RS; Carano K; Halton KP
    Comput Med Imaging Graph; 1999; 23(3):165-8. PubMed ID: 10397360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of recurrent pneumatosis cystoides intestinalis associated with recurrent pneumoperitoneum].
    Park JY; Yoon JY; Min SY; Hong SK; Park JS; Jang EJ; Baik HW; Park SJ
    Korean J Gastroenterol; 2007 Sep; 50(3):188-92. PubMed ID: 17885285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumatosis intestinalis following cytotoxic or immunosuppressive treatment.
    Galm O; Fabry U; Adam G; Osieka R
    Digestion; 2001; 64(2):128-32. PubMed ID: 11684828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumatosis intestinalis associated with lenvatinib during thyroid cancer treatment: a case report.
    Toda S; Iwasaki H; Murayama D; Isoda M; Nakayama H; Suganuma N; Masudo K
    J Med Case Rep; 2021 Nov; 15(1):556. PubMed ID: 34763724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prednisolone induced pneumatosis coli and pneumoperitoneum.
    Goh SSN; Shelat V
    World J Gastroenterol; 2022 Jul; 28(28):3739-3742. PubMed ID: 36161037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pneumoperitoneum due to intestinal cystic pneumatosis associated with a tyrosine kinase inhibitor.
    Martín-Lagos Maldonado A; Lozano Cejudo C; Sáenz Lozano A
    Rev Esp Enferm Dig; 2018 Aug; 110(8):531-532. PubMed ID: 29900744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumatosis cystoides intestinalis mimicking free intraabdominal air following chemotherapy for relapsed acute myeloblastic leukemia in a transplanted neutropenic child: a case report.
    Aygüneş U; Karagün BŞ; Şaşmaz İ; Tutuş K; Özden Ö; Antmen B
    Turk J Pediatr; 2023; 65(4):693-697. PubMed ID: 37661686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumatosis cystoides intestinalis associated with sunitinib and a literature review.
    Lee YS; Han JJ; Kim SY; Maeng CH
    BMC Cancer; 2017 Nov; 17(1):732. PubMed ID: 29121860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment with hyperbaric oxygen therapy for pneumatosis cystoides intestinalis as a complication of granulomatosis with polyangiitis: a case report.
    Nakatani K; Kato T; Okada S; Matsumoto R; Nishida K; Komuro H; Suganuma T
    J Med Case Rep; 2017 Sep; 11(1):263. PubMed ID: 28917259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A Case of Pneumatosis Cystoides Intestinalis Secondary to Gefitinib Therapy for Lung Adenocarcinoma].
    Ando T; Sakata J; Maruyama T; Hirose Y; Okabe Y; Takizawa K; Nagahashi M; Shimada Y; Ishikawa T; Kameyama H; Kobayashi T; Minagawa M; Kosugi S; Koyama Y; Ohtsubo A; Watanabe S; Wakai T
    Gan To Kagaku Ryoho; 2015 Jul; 42(7):847-9. PubMed ID: 26197747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumatosis intestinalis and spontaneous perforation associated with drug toxicity in oncologic patients: a case series.
    Brocchi S; Parmeggiani A; Gaudiano C; Balacchi C; Renzulli M; Brandi N; Dall'Olio FG; Rihawi K; Ardizzoni A; Golfieri R
    Acta Gastroenterol Belg; 2021; 84(3):497-499. PubMed ID: 34599575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.